Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour Investigations, Brighton, England, October 24-28, 1983 - Developments in Oncology 23 (Paperback)
  • Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour Investigations, Brighton, England, October 24-28, 1983 - Developments in Oncology 23 (Paperback)
zoom

Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour Investigations, Brighton, England, October 24-28, 1983 - Developments in Oncology 23 (Paperback)

(author), (author), (author)
£139.99
Paperback 585 Pages / Published: 17/10/2011
  • We can order this

Usually dispatched within 3 weeks

  • This item has been added to your basket
Over the past 30 years many significant advances have been made in the management of a number of disseminated malignant diseases. The prognosis for diseases such as childhood leukaemia, choriocarcinoma and Hodgkin's disease has gradually been transformed as better anti tumour agents have become available and their clinical use has been refined. During the past 10 years the advent of new agents, particularly cisplatin, bleomycin and the podophyllotoxins, has allowed the cure of disseminated testicular tumours. This degree of success has not, however, been achieved in the case of a number of other common cancers. Ovarian carcinoma is tantalisingly chemo-sensitive and although there are long term survivors from disseminated disease, these are only a small proportion of the total. Breast cancer, although "sensitive" to a multitude of drugs appears to have yielded neither survival benefit, nor cure to the efforts of therapists, while tumours such as those of the colon remain stubbornly unresponsive. Against this backcloth it is apparent that additional more selective treatments are needed if further impact is to be made on the problem of cancer. The development of such agents requires the integration of a multidisciplinary effort encompassing the fields of chemistry, biology and medicine. This symposium provided a forum for clinical and preclinical sCientists, where current aspects of cancer treatment were reviewed and approaches to the development of a new generation of more selective anticancer drugs discussed.

Publisher: Springer-Verlag New York Inc.
ISBN: 9781461338390
Number of pages: 585
Weight: 932 g
Dimensions: 235 x 155 x 31 mm
Edition: Softcover reprint of the original 1st ed. 198

You may also be interested in...

Cancer Virus
Added to basket
Survival Lessons
Added to basket
Beat Cancer
Added to basket
£14.99
Paperback
Oxford Handbook of Oncology
Added to basket
£34.99
Part-work (fascículo)
When I Die
Added to basket
£8.99
Paperback
Physics for Clinical Oncology
Added to basket
Cancer
Added to basket
£12.50
Paperback
The Cancer Chronicles
Added to basket
Oxford Handbook of Clinical Haematology
Added to basket
£34.99
Part-work (fascículo)
Mum's Not Having Chemo
Added to basket
B is for Breast Cancer
Added to basket
The Emperor of All Maladies
Added to basket
Beating Cancer with Nutrition
Added to basket
Lecture Notes: Oncology
Added to basket

Reviews

Please sign in to write a review

Your review has been submitted successfully.